To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C7orf55andLUC7L2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
629 supporting clones for gene C7orf55andLUC7L2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AW183444 pooled .a 1 to 234 1 to 233   tiling clone, Submitted on the opposite strand 233/233
(100 %)
2 diff
(99.2 %id)
AI807173 pooled .a 2 to 480 14 to 492     Submitted on the opposite strand 479/492
(97 %)
6 diff
(98.8 %id)
BQ376288 testis_normal .a 77 to 273 24 to 219   tiling clone,   196/236
(83 %)
3 diff
(98.8 %id)
BX090853 pooled .a 152 to 536 385 to 1   tiling clone, Submitted on the opposite strand 385/385
(100 %)
0 diff
(100 %id)
BI461196 testis .a 445 to 1233 794 to 6   tiling clone, Submitted on the opposite strand 789/794
(99 %)
0 diff
(100 %id)
BM468402 leiomyosarcoma, uterus .a 840 to 1688 1 to 853       853/1064
(80 %)
18 diff
(98.4 %id)
DA046253 bladder .a 842 to 1415 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DA643926   .a 856 to 1447 2 to 593   capped   592/592
(100 %)
1 diff
(99.9 %id)
NM_016019.2   .a 858 to 3522 1 to 2665 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 2665/2665
(100 %)
0 diff
(100 %id)
DA300625 hippocampus .a 859 to 1437 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DA342563 substantia nigra .a 859 to 1429 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA667899 esophagus .a 859 to 1417 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BP217734 caudate nucleus .a 862 to 1444 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
BP231647 muscle .a 862 to 1443 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BJ994045 hepatoblastoma .a 862 to 1293 1 to 432       432/450
(96 %)
2 diff
(99.6 %id)
DA043962 bladder .a 865 to 1440 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA585604 lung .a 865 to 1461 2 to 598   capped   597/597
(100 %)
1 diff
(99.9 %id)
DB212087 trachea .a 865 to 1403 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
CR613966 Placenta Cot 25-normalized .a 866 to 3195 1 to 2330 exact     2330/2330
(100 %)
0 diff
(100 %id)
AL545714 placenta, Placenta Cot 25-normalized .a 866 to 2008 1 to 1138       995/1141
(87 %)
27 diff
(97.7 %id)
BQ878672 dorsal root ganglia .a 868 to 1735 20 to 901       882/926
(95 %)
37 diff
(96.1 %id)
DA746095   .a 868 to 1435 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
BJ990449 hepatoblastoma .a 870 to 1452 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DA297476 hippocampus .a 871 to 1451 2 to 582   capped   581/582
(99 %)
2 diff
(99.7 %id)
DB259572 uterus .a 871 to 1374 2 to 505   capped   504/504
(100 %)
0 diff
(100 %id)
DA939555 Spleen .a 877 to 1103 2 to 228   capped   227/227
(100 %)
0 diff
(100 %id)
AK001519   .a 878 to 3522 1 to 2645 R119Q available from FLJ,   2645/2645
(100 %)
3 diff
(99.9 %id)
BU506923 leiomyosarcoma, uterus .a 880 to 1598 78 to 798       721/1076
(67 %)
16 diff
(98.6 %id)
CN363785 embryonic stem cells, DMSO-treated H9 cellline .a 882 to 992 1 to 111       111/111
(100 %)
0 diff
(100 %id)
CF593432 Human Placenta, placenta .a 882 to 1520 30 to 672       643/875
(73 %)
11 diff
(98.8 %id)
DA308143 hippocampus .a 885 to 1477 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
BC050708 Uterus, leiomyosarcoma .a 886 to 3271 1 to 2386 exact available from MGC, AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 2386/2386
(100 %)
0 diff
(100 %id)
CN363787 embryonic stem cells, cell lines H1, H7, andH9 .a 890 to 1566 1 to 677       677/677
(100 %)
2 diff
(99.8 %id)
DA317970 hippocampus .a 891 to 1387 2 to 498   capped   497/498
(99 %)
0 diff
(100 %id)
DA381020 thalamus .a 891 to 1453 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA811417 brain .a 895 to 1433 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA021781   .a 898 to 1469 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA077396 cerebellum .a 898 to 1461 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA373081 thalamus .a 898 to 1524 2 to 629   capped   628/628
(100 %)
1 diff
(99.9 %id)
DA778650 brain .a 898 to 1476 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DB242065 stomach, tumor tissue .a 898 to 1387 2 to 491   capped   490/491
(99 %)
0 diff
(100 %id)
DB259350 uterus .a 898 to 1470 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
BC017163 Skin, melanotic melanoma. .a 899 to 3522 1 to 2624 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 2624/2624
(100 %)
0 diff
(100 %id)
BP211677 cerebrum .a 900 to 1480 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
DA041041 bladder .a 901 to 1471 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA053541   .a 901 to 1501 2 to 602   capped   601/601
(100 %)
0 diff
(100 %id)
DA145930 amygdala .a 901 to 1479 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA302045 hippocampus .a 901 to 1473 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA510723 brain .a 901 to 1473 2 to 576   capped   575/575
(100 %)
3 diff
(99.5 %id)
DA816165   .a 901 to 1469 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DB205098 trachea .a 901 to 1488 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
BX424532 neuroblastoma .a 907 to 1740 1 to 832       832/832
(100 %)
10 diff
(98.8 %id)
BX425379 neuroblastoma .a 907 to 1777 1 to 872       872/872
(100 %)
3 diff
(99.7 %id)
DA291073 hippocampus .a 909 to 1483 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA352662 substantia nigra .a 909 to 1454 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
BE891932 melanotic melanoma, skin .a 909 to 1103 1 to 195       195/195
(100 %)
0 diff
(100 %id)
DA266776 caudate nucleus .a 916 to 1466 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA450595 tongue, tumor tissue .a 916 to 1483 2 to 574   capped   573/573
(100 %)
5 diff
(99.2 %id)
DR761397 embryonic stem .a 916 to 1603 1 to 688       688/688
(100 %)
0 diff
(100 %id)
DB238179 trachea .a 916 to 1502 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
DA481265   .a 917 to 1458 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
CD172472 White Matter .a 919 to 1739 1 to 822       822/857
(95 %)
10 diff
(98.9 %id)
CA771537 Pancreas, Purified pancreatic islet .a 920 to 1552 1 to 634       634/634
(100 %)
8 diff
(98.8 %id)
AK001476   .a 924 to 3251 1 to 2328 exact available from FLJ,   2328/2328
(100 %)
2 diff
(100.0 %id)
DA475684   .a 924 to 1486 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DB161526 thymus .a 924 to 1496 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA388771 thalamus .a 925 to 1502 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DA449869 tongue, tumor tissue .a 925 to 1500 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA875432 Prostate .a 925 to 1498 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA929152 small intestine .a 926 to 1489 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB206348 trachea .a 926 to 1509 2 to 586   capped   585/585
(100 %)
2 diff
(99.7 %id)
DA039333 bladder .a 927 to 1478 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA158629 amygdala .a 927 to 1454 2 to 529   capped   528/528
(100 %)
0 diff
(100 %id)
DA297768 hippocampus .a 927 to 1503 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA390908 thalamus .a 927 to 1511 2 to 586   capped   585/585
(100 %)
3 diff
(99.5 %id)
DA558195   .a 927 to 1481 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
TI_44169089   .a 928 to 1174 86 to 331       246/340
(72 %)
8 diff
(97.7 %id)
DA020817   .a 930 to 1489 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
AL517220 brain, neuroblastoma, neuroblastoma cells .a 930 to 1900 1 to 969       969/1031
(93 %)
8 diff
(99.3 %id)
CN363791 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 932 to 1605 1 to 674       674/674
(100 %)
0 diff
(100 %id)
TI_149286698   .a 935 to 1386 528 to 74       453/1296
(34 %)
0 diff
(100 %id)
DB252371 uterus .a 939 to 1509 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
DR759695 embryonic stem .a 940 to 1768 1 to 829       829/829
(100 %)
0 diff
(100 %id)
AK022895   .a 941 to 3267 1 to 2327 exact available from FLJ,   2327/2327
(100 %)
0 diff
(100 %id)
BC056886 Skin, melanotic melanoma. .a 941 to 3185 1 to 2245 exact available from MGC, AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 2245/2245
(100 %)
1 diff
(100.0 %id)
AU128291   .a 942 to 1585 2 to 646   capped   645/648
(99 %)
5 diff
(99.3 %id)
BU154386 eye, retinoblastoma .a 943 to 1850 1 to 911       911/915
(99 %)
15 diff
(98.4 %id)
BU188678 melanotic melanoma, skin .a 943 to 1793 1 to 855       855/865
(98 %)
8 diff
(99.1 %id)
CA405542 adipose .a 952 to 1236 1 to 285       285/285
(100 %)
0 diff
(100 %id)
TI_154152666   .a 952 to 1461 79 to 588       510/511
(99 %)
5 diff
(99.1 %id)
BE783969 eye, retinoblastoma .a 962 to 1153 1 to 192       192/192
(100 %)
0 diff
(100 %id)
CN363788 embryonic stem cells, DMSO-treated H9 cellline .a 971 to 1493 1 to 523       523/523
(100 %)
0 diff
(100 %id)
TI_154148368   .a 984 to 1548 79 to 641       563/564
(99 %)
4 diff
(99.3 %id)
CR997354 T-Lymphocytes .a 1012 to 1720 1 to 709       709/712
(99 %)
3 diff
(99.6 %id)
DB177606 kidney, tumor tissue .a 1018 to 1564 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
TI_154146235   .a 1023 to 1699 79 to 753       675/676
(99 %)
16 diff
(97.7 %id)
CN363793 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1083 to 1731 1 to 650       650/650
(100 %)
3 diff
(99.6 %id)
CR987768 T-Lymphocytes .a 1157 to 2053 1 to 897       897/897
(100 %)
2 diff
(99.8 %id)
AW999068 breast_normal .a 1199 to 1598 431 to 32     Submitted on the opposite strand 402/431
(93 %)
8 diff
(98.2 %id)
CD299945 testis .a 1212 to 2077 1 to 871       869/881
(98 %)
11 diff
(98.8 %id)
TI_1948076947   .a 1231 to 1949 134 to 852   fully sequenced,   719/852
(84 %)
6 diff
(99.3 %id)
TI_1948077286   .a 1231 to 1949 135 to 852   fully sequenced,   718/852
(84 %)
6 diff
(99.3 %id)
TI_1948077456   .a 1231 to 1949 135 to 853   fully sequenced,   719/853
(84 %)
6 diff
(99.3 %id)
AF151832   .a 1232 to 3524 1 to 2294       2294/2296
(99 %)
5 diff
(99.8 %id)
CV023343 mixed .a 1232 to 1862 1 to 631       631/637
(99 %)
1 diff
(99.9 %id)
TI_154196623   .a 1237 to 1985 17 to 765       749/1057
(70 %)
28 diff
(97.4 %id)
TI_154197007   .a 1237 to 2017 98 to 874       778/1029
(75 %)
24 diff
(97.7 %id)
BQ375342 testis_normal .a 1239 to 1742 512 to 12       500/512
(97 %)
1 diff
(99.9 %id)
TI_1948077113   .a 1242 to 2040 138 to 935   fully sequenced,   798/935
(85 %)
8 diff
(99.2 %id)
AF151817   .a 1257 to 3233 1 to 1976       1976/1976
(100 %)
8 diff
(99.6 %id)
AA307963 colon .a 1286 to 1762 1 to 477       477/477
(100 %)
0 diff
(100 %id)
DA737505   .a 1507 to 2218 2 to 716   capped   715/817
(87 %)
10 diff
(98.8 %id)
CX781630 human embryonic stem cells .a 1634 to 2481 1 to 848     Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 848/848
(100 %)
1 diff
(99.9 %id)
CX869594 embryonic stem .a 1680 to 2481 1 to 802       802/802
(100 %)
0 diff
(100 %id)
BQ230414 epithelioid carcinoma, Pancreas .a 1834 to 2687 1 to 857       857/857
(100 %)
5 diff
(99.5 %id)
CX870629 embryonic stem .a 1856 to 2707 1 to 852       852/852
(100 %)
0 diff
(100 %id)
BF792609 adrenal cortex carcinoma, cell line, adrenal gland .a 1886 to 2655 1 to 773       773/851
(90 %)
10 diff
(98.9 %id)
TI_1948076948   .a 1888 to 2416 647 to 119   fully sequenced,   529/647
(81 %)
0 diff
(100 %id)
TI_1948077287   .a 1888 to 2416 647 to 119   fully sequenced,   529/647
(81 %)
0 diff
(100 %id)
TI_1948077457   .a 1888 to 2416 646 to 118   fully sequenced,   529/646
(81 %)
0 diff
(100 %id)
CD244528 testis .a 1901 to 2647 1 to 755       755/850
(88 %)
15 diff
(98.3 %id)
Z44294 brain, total brain .a 1910 to 2237 1 to 329       329/329
(100 %)
4 diff
(98.8 %id)
CU444750 epidermis .a 1958 to 2763 807 to 1     Submitted on the opposite strand 807/807
(100 %)
7 diff
(99.2 %id)
TI_1948077114   .a 1980 to 2416 555 to 119   fully sequenced,   437/555
(78 %)
0 diff
(100 %id)
AL571328 placenta, Placenta Cot 25-normalized .a 2009 to 3195 1187 to 1       1187/1187
(100 %)
20 diff
(98.4 %id)
Z44289 brain, total brain .a 2019 to 2367 1 to 349       349/349
(100 %)
0 diff
(100 %id)
AL561696 brain, neuroblastoma, neuroblastoma cells .a 2050 to 3212 1156 to 1       1156/1163
(99 %)
29 diff
(97.6 %id)
BQ428913 testis .a 2118 to 2895 1 to 781       781/783
(99 %)
13 diff
(98.4 %id)
CR603944 Neuroblastoma Cot 25-normalized .a 2188 to 3184 1 to 997       997/997
(100 %)
0 diff
(100 %id)
BX387474 Neuroblastoma Cot 25-normalized .a 2188 to 3045 1 to 857       857/857
(100 %)
5 diff
(99.5 %id)
BX387475 Neuroblastoma Cot 25-normalized .a 2188 to 3179 1 to 984       984/988
(99 %)
19 diff
(98.1 %id)
BG483234 lung .a 2194 to 2907 1 to 715       715/716
(99 %)
19 diff
(97.4 %id)
BM715050 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2285 to 2737 1 to 453   fully sequenced, Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 453/453
(100 %)
0 diff
(100 %id)
TI_149286884   .a 2287 to 3226 996 to 62   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 935/1171
(79 %)
33 diff
(97.2 %id)
TI_154123552   .a 2332 to 3216 974 to 92   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 883/1006
(87 %)
10 diff
(99.1 %id)
DR421750 eye, Pterygium .a 2341 to 3042 1 to 702       702/702
(100 %)
0 diff
(100 %id)
CD522979 pooled .a 2356 to 3134 1 to 800       800/886
(90 %)
39 diff
(95.6 %id)
TI_154059094   .a 2368 to 3226 937 to 88   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 850/1038
(81 %)
28 diff
(97.4 %id)
TI_159690737   .a 2377 to 2852 984 to 507       478/1135
(42 %)
0 diff
(100 %id)
BE737556 brain, glioblastoma .a 2384 to 2992 1 to 606       606/872
(69 %)
6 diff
(99.4 %id)
BX417688 placenta .a 2419 to 3506 1080 to 1       1080/1090
(99 %)
20 diff
(98.2 %id)
BX387473 Neuroblastoma Cot 25-normalized .a 2425 to 3506 1070 to 1       1070/1074
(99 %)
24 diff
(97.8 %id)
CA419016 Chondrosarcoma Grade II, Left Pelvis .a 2457 to 3216 778 to 19   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 760/760
(100 %)
3 diff
(99.7 %id)
BU183623 melanotic melanoma, skin .a 2479 to 3235 1 to 759       759/874
(86 %)
10 diff
(98.9 %id)
TI_154118965   .a 2504 to 3265 884 to 129       756/1083
(69 %)
0 diff
(100 %id)
TI_154103594   .a 2509 to 3216 792 to 88   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 705/809
(87 %)
28 diff
(96.6 %id)
BQ028472 mixed .a 2541 to 3205 664 to 1       664/664
(100 %)
0 diff
(100 %id)
BY996158   .a 2555 to 3220 29 to 694   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 666/694
(95 %)
6 diff
(99.2 %id)
CX869513 embryonic stem .a 2561 to 3223 691 to 29       663/691
(95 %)
0 diff
(100 %id)
CX781561 human embryonic stem cells .a 2565 to 3271 732 to 26   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 707/707
(100 %)
1 diff
(99.9 %id)
BX387472 Neuroblastoma Cot 25-normalized .a 2570 to 3491 924 to 1       924/924
(100 %)
26 diff
(97.2 %id)
BM991949 Bone, Subchondral Bone .a 2572 to 3220 667 to 19   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 649/649
(100 %)
0 diff
(100 %id)
AI185631 lung .a 2585 to 3233 647 to 1       647/647
(100 %)
1 diff
(99.9 %id)
BU615313 Bone, Human Chondrosarcoma Cell Line .a 2586 to 3242 675 to 19   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 657/657
(100 %)
0 diff
(100 %id)
CA419495 Bone, Human Chondrosarcoma Cell Line .a 2587 to 3226 657 to 19   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 639/639
(100 %)
2 diff
(99.7 %id)
AI741055 pooled .a 2588 to 3207 629 to 9       621/629
(98 %)
0 diff
(100 %id)
BU616613 Bone, Subchondral Bone .a 2588 to 3232 663 to 19   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 645/645
(100 %)
0 diff
(100 %id)
CA439195 lung, Lung Focal Fibrosis .a 2605 to 3242 652 to 19   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 634/634
(100 %)
7 diff
(98.9 %id)
CA771229 Pancreas, Purified pancreatic islet .a 2627 to 3231 605 to 1       605/605
(100 %)
0 diff
(100 %id)
BQ002903 Chondrosarcoma, Left Pelvis .a 2629 to 3223 613 to 19   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 595/595
(100 %)
4 diff
(99.4 %id)
CA312078 Human Lung Epithelial cells, lung .a 2647 to 3271 643 to 19   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 625/641
(97 %)
0 diff
(100 %id)
BJ990450 hepatoblastoma .a 2664 to 3143 480 to 1       480/480
(100 %)
2 diff
(99.6 %id)
BQ631639 Pancreas, Purified pancreatic islet .a 2679 to 3137 1 to 459       459/459
(100 %)
0 diff
(100 %id)
BE738547 brain, glioblastoma .a 2707 to 3468 765 to 4       762/1022
(74 %)
0 diff
(100 %id)
BU739958 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2707 to 3219 528 to 16   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 513/513
(100 %)
0 diff
(100 %id)
DB247572 uterus .a 2718 to 3286 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
AW130460 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2728 to 2931 204 to 1       204/204
(100 %)
0 diff
(100 %id)
AI434521 lymph node, lymphoma, follicular mixed small and largecell .a 2729 to 2931 203 to 1       203/203
(100 %)
0 diff
(100 %id)
AI925399 adenocarcinoma, Pancreas .a 2732 to 2931 200 to 1       200/200
(100 %)
0 diff
(100 %id)
AI831160 lymph node, lymphoma, follicular mixed small and largecell .a 2779 to 2931 153 to 1       153/153
(100 %)
0 diff
(100 %id)
EC526710 Prostate .a 2786 to 2899 1 to 117       117/117
(100 %)
6 diff
(94.9 %id)
AW166162 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2794 to 2931 138 to 1       138/138
(100 %)
0 diff
(100 %id)
AI933708 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2806 to 2931 126 to 1       126/126
(100 %)
0 diff
(100 %id)
AI061330   .a 2818 to 3208 391 to 1       391/391
(100 %)
0 diff
(100 %id)
CA429737 Cell Line, Chondrosarcoma .a 2826 to 3522 717 to 20   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 698/698
(100 %)
1 diff
(99.9 %id)
BM894401 insulinoma, Pancreas .a 2839 to 3223 8 to 393   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 386/393
(98 %)
7 diff
(98.3 %id)
CA429685 Cell Line, Chondrosarcoma .a 2843 to 3522 699 to 20   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 680/689
(98 %)
1 diff
(99.9 %id)
CR743495   .a 2878 to 3271 408 to 15   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 394/394
(100 %)
0 diff
(100 %id)
AI471233 brain, glioblastoma (pooled) .a 2912 to 3251 340 to 1       340/340
(100 %)
0 diff
(100 %id)
Z40253 brain, total brain .a 2929 to 3232 304 to 1       304/304
(100 %)
1 diff
(99.7 %id)
AW591086 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 2946 to 3202 283 to 27   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 257/257
(100 %)
0 diff
(100 %id)
AW516387 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2946 to 3216 271 to 1       271/271
(100 %)
0 diff
(100 %id)
AW662619 colon, moderately-differentiated adenocarcinoma .a 2946 to 3221 276 to 1       276/276
(100 %)
0 diff
(100 %id)
BM894126 insulinoma, Pancreas .a 2948 to 3222 295 to 21   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 275/275
(100 %)
1 diff
(99.7 %id)
BQ332410 lung_tumor .a 2987 to 3115 8 to 134       127/150
(84 %)
11 diff
(92.7 %id)
AU154525   .a 2993 to 3525 532 to 1       532/532
(100 %)
3 diff
(99.5 %id)
AI858267 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2997 to 3523 527 to 1       527/527
(100 %)
0 diff
(100 %id)
AW612540 Kidney .a 2997 to 3518 522 to 1       522/522
(100 %)
0 diff
(100 %id)
BE349540 malignant melanoma, metastatic to lymphnode, skin .a 2998 to 3523 526 to 1       526/526
(100 %)
0 diff
(100 %id)
F03432 brain, total brain .a 3004 to 3226 223 to 1       223/223
(100 %)
1 diff
(99.6 %id)
AA745246 germinal center B cell .a 3039 to 3522 499 to 16   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 484/484
(100 %)
0 diff
(100 %id)
AI951954 brain, four pooled pituitary adenomas .a 3062 to 3522 461 to 1       461/461
(100 %)
0 diff
(100 %id)
AW104740 ovary, tumor, 5 pooled (see description) .a 3068 to 3522 455 to 1       455/455
(100 %)
0 diff
(100 %id)
BU960265 mixed (pool of 40 RNAs) .a 3085 to 3216 1 to 132   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 132/136
(97 %)
2 diff
(98.6 %id)
BJ994046 hepatoblastoma .a 3101 to 3486 388 to 1       388/388
(100 %)
1 diff
(99.8 %id)
BE349920 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 3127 to 3522 396 to 1       396/396
(100 %)
0 diff
(100 %id)
BM151169 leukopheresis .a 3127 to 3518 411 to 20   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 392/392
(100 %)
2 diff
(99.5 %id)
AW016157   .a 3149 to 3522 391 to 18   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 374/374
(100 %)
0 diff
(100 %id)
BE463986 pooled germ cell tumors .a 3186 to 3526 341 to 1       341/341
(100 %)
0 diff
(100 %id)
AI672400 Kidney .a 3210 to 3523 314 to 1       314/314
(100 %)
0 diff
(100 %id)
BM150544 leukopheresis .a 3210 to 3518 327 to 20   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 308/332
(92 %)
15 diff
(95.5 %id)
EC483363 Prostate .a 3249 to 3341 11 to 102       92/105
(87 %)
5 diff
(95.3 %id)
BU161198 melanotic melanoma, skin .a 3353 to 4176 1 to 835   tiling clone,   835/879
(94 %)
16 diff
(98.2 %id)
AK297642 brain .b 1 to 1657 5 to 1661 exact tiling clone,   1661/1661
(100 %)
0 diff
(100 %id)
DC354017 brain .b 1 to 603 5 to 607       607/607
(100 %)
0 diff
(100 %id)
AL698026 human skeletal muscle .b 6 to 211 1 to 208       208/208
(100 %)
3 diff
(98.6 %id)
F26944 pectoral muscle (after mastectomy) .b 42 to 204 1 to 162       162/162
(100 %)
1 diff
(99.4 %id)
FN095095 breast carcinoma .b 193 to 247 1 to 55       55/55
(100 %)
0 diff
(100 %id)
BX390273 Placenta Cot 25-normalized .b 674 to 1590 1 to 916       916/916
(100 %)
12 diff
(98.7 %id)
TI_57229844   .b 706 to 1372 53 to 719       667/667
(100 %)
0 diff
(100 %id)
BI870898 adenocarcinoma, cell line, Liver .b 708 to 1372 1 to 665       665/665
(100 %)
0 diff
(100 %id)
CB134583 Liver .b 719 to 1315 1 to 597       597/597
(100 %)
0 diff
(100 %id)
BF696454 brain, primitive neuroectoderm .b 979 to 1607 1 to 638       638/785
(81 %)
16 diff
(98.0 %id)
FN126618 breast carcinoma .b 1260 to 1318 59 to 1     Submitted on the opposite strand 59/60
(98 %)
0 diff
(100 %id)
FN061732 breast carcinoma .b 1306 to 1384 79 to 1     Submitted on the opposite strand 79/79
(100 %)
0 diff
(100 %id)
FN093309 breast carcinoma .b 1342 to 1410 1 to 69       69/69
(100 %)
0 diff
(100 %id)
FN150443 breast carcinoma .b 1397 to 1499 1 to 102       102/102
(100 %)
1 diff
(99.1 %id)
FN101887 breast carcinoma .b 1418 to 1513 1 to 98       98/98
(100 %)
2 diff
(98.0 %id)
FN130135 breast carcinoma .b 1481 to 1577 1 to 99       99/99
(100 %)
6 diff
(94.0 %id)
EC473405 Prostate .b 1550 to 1654 1 to 105       105/105
(100 %)
0 diff
(100 %id)
BC042625 Brain, Lung, Testis, adult, pooled whole .c 1 to 2375 1 to 2375 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 2375/2375
(100 %)
0 diff
(100 %id)
DA357802 subthalamic nucleus .c 17 to 585 2 to 573   capped   572/572
(100 %)
3 diff
(99.5 %id)
BE843212 testis_normal .c 430 to 701 1 to 272       272/272
(100 %)
6 diff
(97.8 %id)
AK298166   .d 1 to 1525 1 to 1525 exact tiling clone,   1525/1525
(100 %)
1 diff
(100.0 %id)
DC360356   .d 1 to 572 1 to 572       572/572
(100 %)
1 diff
(99.9 %id)
CU448183 epidermis .d 236 to 872 22 to 658       637/658
(96 %)
10 diff
(98.5 %id)
TI_154195471   .d 236 to 860 14 to 639       626/991
(63 %)
20 diff
(98.0 %id)
BP372677 umbilical cord .d 239 to 818 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
AA496763   .d 260 to 650 1 to 391       391/391
(100 %)
0 diff
(100 %id)
AI821197   .d 260 to 730 1 to 471       471/471
(100 %)
0 diff
(100 %id)
DA223157 brain .d 264 to 825 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
CX167178 human embryonic stem cells differentiated toan early endodermal cell type .d 264 to 1082 1 to 819       819/819
(100 %)
0 diff
(100 %id)
BE926029 breast_normal .d 271 to 542 314 to 40       277/339
(81 %)
3 diff
(99.2 %id)
BI254752 cervical carcinoma cell line, cervix .d 311 to 981 1 to 669       669/683
(97 %)
7 diff
(99.0 %id)
BX350056 Placenta Cot 25-normalized .d 325 to 1139 815 to 1       815/900
(90 %)
14 diff
(98.5 %id)
BF757326 colon .d 332 to 505 190 to 20     Submitted on the opposite strand 171/207
(82 %)
1 diff
(99.6 %id)
CD358711 testis .d 352 to 1217 1 to 866       866/866
(100 %)
8 diff
(99.1 %id)
BF759135 colon .d 357 to 529 174 to 1     Submitted on the opposite strand 174/174
(100 %)
6 diff
(96.6 %id)
CN363784 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 378 to 1168 1 to 792       792/792
(100 %)
1 diff
(99.9 %id)
BQ719168 sympathetic trunk .d 390 to 1176 1 to 787       787/908
(86 %)
4 diff
(99.6 %id)
DA870427 Prostate .d 411 to 862 2 to 453   capped   452/461
(98 %)
0 diff
(100 %id)
AU138669 placenta .d 423 to 1133 2 to 712   capped   711/714
(99 %)
8 diff
(98.9 %id)
DA555295   .d 426 to 978 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
BG286707 bladder, transitional cell papilloma, cell line .d 431 to 1149 17 to 740       722/951
(75 %)
25 diff
(97.4 %id)
DA935301 Spleen .d 452 to 1053 2 to 604   capped   603/603
(100 %)
1 diff
(99.9 %id)
DB265722 uterus .d 456 to 1044 2 to 591   capped   590/590
(100 %)
2 diff
(99.7 %id)
CF141717 CNCAP(3)T-225 cell line, Prostate .d 464 to 904 8 to 448       441/448
(98 %)
0 diff
(100 %id)
TI_154172500   .d 464 to 1143 88 to 767       680/1107
(61 %)
25 diff
(97.8 %id)
BP337275 coronary artery .d 480 to 1063 1 to 583       583/583
(100 %)
5 diff
(99.2 %id)
DR760148 embryonic stem .d 488 to 1272 1 to 785       785/785
(100 %)
1 diff
(99.9 %id)
TI_154183311   .d 494 to 1270 77 to 841       765/778
(98 %)
25 diff
(96.8 %id)
BM829518 Ascites, stomach .d 562 to 1169 1 to 607       607/607
(100 %)
1 diff
(99.9 %id)
BG024658 lymph, lymphoma, cell line .d 565 to 1321 1 to 758       758/791
(95 %)
13 diff
(98.4 %id)
CN363789 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 592 to 1207 1 to 617       617/617
(100 %)
1 diff
(99.9 %id)
BG430399 Kidney .d 593 to 1371 1 to 787       787/820
(95 %)
25 diff
(97.0 %id)
BX477961   .d 674 to 1151 1 to 478       478/478
(100 %)
0 diff
(100 %id)
CB136226 Liver .d 675 to 1156 1 to 482       482/482
(100 %)
0 diff
(100 %id)
BE906604 epithelioid carcinoma, Pancreas .d 715 to 1370 1 to 655       655/833
(78 %)
5 diff
(99.4 %id)
AI940514 colon .d 772 to 1064 293 to 1       293/294
(99 %)
0 diff
(100 %id)
GD150324   .d 772 to 919 1 to 148       148/156
(94 %)
5 diff
(96.8 %id)
EC483959 Prostate .d 826 to 906 1 to 82       82/85
(96 %)
2 diff
(97.7 %id)
CU448450 epidermis .d 876 to 992 129 to 13     Submitted on the opposite strand 117/140
(83 %)
1 diff
(99.3 %id)
BG982990 colon_normal .d 1096 to 1216 121 to 1       121/121
(100 %)
2 diff
(98.4 %id)
DA235654 brain .e 1 to 568 2 to 569   tiling clone, capped   568/568
(100 %)
1 diff
(99.9 %id)
AK092044   .e 546 to 3382 1 to 2837 D26G tiling clone, available from FLJ,   2837/2837
(100 %)
1 diff
(100.0 %id)
DA651840   .e 547 to 1114 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB161804 thymus .e 610 to 1198 2 to 590   capped   589/589
(100 %)
2 diff
(99.7 %id)
DA341510 substantia nigra .e 613 to 1180 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
AW390509 stomach .e 649 to 1190 118 to 660       543/543
(100 %)
3 diff
(99.5 %id)
BX956374   .e 800 to 1323 1 to 524       524/524
(100 %)
0 diff
(100 %id)
BE176840 head_neck .e 860 to 1498 13 to 649       637/669
(95 %)
12 diff
(98.3 %id)
DA208875 brain .e 878 to 1440 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DN990758 brain, whole brain .e 939 to 1469 32 to 562       531/562
(94 %)
6 diff
(99.0 %id)
CB140962 Liver .e 985 to 1496 1 to 512       512/512
(100 %)
0 diff
(100 %id)
BF798293 colon_ins .e 988 to 1194 6 to 213       208/213
(97 %)
6 diff
(97.2 %id)
BF740944 bocio_tumor .e 1060 to 1552 14 to 514       501/514
(97 %)
6 diff
(98.9 %id)
BF898703 marrow .e 1081 to 1269 1 to 191       191/191
(100 %)
2 diff
(99.0 %id)
BG993923 head_neck .e 1081 to 1557 1 to 476       476/476
(100 %)
2 diff
(99.6 %id)
DA944343 Spleen .e 1118 to 1684 2 to 568   tiling clone, capped   567/567
(100 %)
0 diff
(100 %id)
BI026233 marrow .e 1194 to 1498 1 to 302       302/307
(98 %)
4 diff
(98.7 %id)
BJ998033.
matches multiple genes
Wilms tumor .e 1287 to 1642 245 to 600     also hits gene KSR1andLGALS9 356/600
(59 %)
6 diff
(99.0 %id)
DA129716 alzheimer cortex .e 1301 to 1840 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
CX783976 human embryonic stem cells .e 1351 to 2029 49 to 727       550/740
(74 %)
42 diff
(94.4 %id)
DB321717   .e 2833 to 3382 551 to 1       551/551
(100 %)
2 diff
(99.7 %id)
DA548684   .f 1 to 576 2 to 577   tiling clone, capped   576/576
(100 %)
0 diff
(100 %id)
DB263283 uterus .f 536 to 1126 2 to 593   capped   592/592
(100 %)
1 diff
(99.9 %id)
DA849765 placenta .f 545 to 1099 2 to 556   tiling clone, capped   555/555
(100 %)
0 diff
(100 %id)
DA938693 Spleen .f 632 to 1222 2 to 592   capped   591/591
(100 %)
1 diff
(99.9 %id)
DR158129 human embryonic stem cells differentiated toan early endodermal cell type .f 756 to 1539 1 to 784   tiling clone,   784/784
(100 %)
0 diff
(100 %id)
BG532110 embryonal carcinoma, testis .f 890 to 1617 1 to 732       732/733
(99 %)
13 diff
(98.3 %id)
BG290283 bladder, transitional cell papilloma, cell line .f 985 to 1575 28 to 612       585/676
(86 %)
32 diff
(95.3 %id)
EC458744 Prostate .f 1007 to 1093 9 to 95       87/95
(91 %)
6 diff
(93.7 %id)
BX375843 Neuroblastoma Cot 25-normalized .f 1028 to 1867 1 to 848       848/934
(90 %)
14 diff
(98.6 %id)
BE178663 head_neck .f 1032 to 1354 29 to 351       323/366
(88 %)
1 diff
(99.8 %id)
TI_154034189   .f 1034 to 1935 988 to 84   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 905/947
(95 %)
22 diff
(97.7 %id)
BF748953 breast_normal .f 1090 to 1349 25 to 281       257/281
(91 %)
6 diff
(97.9 %id)
BG426622 Kidney .f 1099 to 1873 1 to 783       783/783
(100 %)
30 diff
(96.2 %id)
CA443359 Fibrosarcoma .f 1182 to 1935 779 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 761/761
(100 %)
4 diff
(99.5 %id)
CV572559 cornea, eye .f 1276 to 1897 1 to 623       623/623
(100 %)
2 diff
(99.7 %id)
CN363311 embryonic stem cells, DMSO-treated H9 cellline .f 1478 to 2035 9 to 566   tiling clone,   558/568
(98 %)
1 diff
(99.9 %id)
AW085712 esophagus, squamous cell carcinoma .f 1546 to 1935 390 to 1       390/390
(100 %)
0 diff
(100 %id)
FN070018 breast carcinoma .f 1555 to 1670 113 to 1     Submitted on the opposite strand 113/113
(100 %)
4 diff
(96.5 %id)
BQ720892 sympathetic trunk .f 1605 to 2389 1 to 793       793/905
(87 %)
16 diff
(98.3 %id)
BE762852 nervous_tumor .f 1631 to 1984 362 to 9       354/362
(97 %)
0 diff
(100 %id)
CN363313 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 1650 to 2370 1 to 721       721/721
(100 %)
1 diff
(99.9 %id)
BM821610 stomach .f 1715 to 2173 1 to 459       459/462
(99 %)
4 diff
(99.2 %id)
AW800403 uterus .f 1743 to 2061 23 to 341       319/342
(93 %)
7 diff
(98.0 %id)
DA728085   .f 1792 to 2474 2 to 684   tiling clone, capped   683/683
(100 %)
1 diff
(99.9 %id)
BI859893 breast, mammary adenocarcinoma, cell line .f 1941 to 2487 1 to 548   tiling clone,   548/549
(99 %)
5 diff
(99.1 %id)
TI_57188793   .f 1941 to 2464 58 to 582   AAA   525/534
(98 %)
3 diff
(99.5 %id)
GD140234   .f 1949 to 2184 240 to 5     Submitted on the opposite strand 236/246
(95 %)
0 diff
(100 %id)
AI963460 adenocarcinoma, Pancreas .f 1991 to 2459 480 to 12   AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 469/469
(100 %)
0 diff
(100 %id)
BX089240 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f 2001 to 2484 483 to 1       483/483
(100 %)
1 diff
(99.8 %id)
AA663192   .f 2004 to 2419 416 to 1       416/416
(100 %)
5 diff
(98.8 %id)
AA229628   .f 2049 to 2213 1 to 164       164/164
(100 %)
6 diff
(96.4 %id)
AI521577 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f 2057 to 2469 413 to 1   tiling clone,   413/413
(100 %)
0 diff
(100 %id)
AW976081   .g 1 to 722 729 to 1   tiling clone, Submitted on the opposite strand 729/729
(100 %)
12 diff
(98.4 %id)
BQ337090 marrow .g 115 to 426 318 to 10   tiling clone,   309/331
(93 %)
0 diff
(100 %id)
TI_154010306   .g 162 to 723 673 to 111   AAA   563/1232
(45 %)
2 diff
(99.9 %id)
AL603478 human skeletal muscle .g 183 to 684 1 to 500       500/500
(100 %)
4 diff
(99.2 %id)
CA435544 lung, Metastatic Chondrosarcoma .g 204 to 723 536 to 17   AAA   520/520
(100 %)
0 diff
(100 %id)
AI694560 carcinoid, lung .g 213 to 736 522 to 1       522/522
(100 %)
6 diff
(98.9 %id)
AA747684 germinal center B cell .g 291 to 723 443 to 11   AAA   433/433
(100 %)
0 diff
(100 %id)
AI084825 liver and spleen .g 316 to 733 415 to 1       415/415
(100 %)
4 diff
(99.1 %id)
BF956859 nervous_normal .g 332 to 828 34 to 528   tiling clone,   495/528
(93 %)
6 diff
(98.9 %id)
DA246551 brain .g 735 to 1310 2 to 577   tiling clone, capped   576/577
(99 %)
1 diff
(99.9 %id)
GD143476   .g 924 to 1081 162 to 1     Submitted on the opposite strand 162/162
(100 %)
10 diff
(93.9 %id)
CR736187 germinal center B cell .g 1173 to 1635 1 to 463   tiling clone,   463/465
(99 %)
1 diff
(99.8 %id)
AI289276 serous papillary carcinoma, high grade, 2pooled tumors, uterus .g 1335 to 1737 2 to 404   tiling clone, Submitted on the opposite strand 403/404
(99 %)
6 diff
(98.6 %id)
BX091727 serous papillary carcinoma, high grade, 2pooled tumors, uterus .g 1338 to 1675 3 to 340     Submitted on the opposite strand 338/340
(99 %)
6 diff
(98.3 %id)
AA827680 germinal center B cell .g 1726 to 2202 479 to 3   tiling clone,   477/479
(99 %)
0 diff
(100 %id)
DA222808 brain .g 1818 to 2351 2 to 536   capped   535/535
(100 %)
2 diff
(99.7 %id)
BX951282   .g 2022 to 2631 1 to 609       609/609
(100 %)
2 diff
(99.7 %id)
BX956741   .g 2046 to 2639 1 to 594   tiling clone,   594/594
(100 %)
0 diff
(100 %id)
DB068144 testis .g 2240 to 2774 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
DB226928 trachea .g 2270 to 2816 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DB100023 testis .g 2287 to 2868 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
DA222242 brain .g 2289 to 2837 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
BM728783 eye, fetal eye .g 2343 to 3033 691 to 2     Submitted on the opposite strand 690/691
(99 %)
0 diff
(100 %id)
DA108309 cerebellum .g 2394 to 2944 2 to 552   capped   551/551
(100 %)
3 diff
(99.5 %id)
DA856604 placenta .g 2546 to 3103 2 to 559   tiling clone, capped   558/558
(100 %)
0 diff
(100 %id)
DA855353 placenta .g 2549 to 3087 2 to 541   capped   540/540
(100 %)
2 diff
(99.7 %id)
AK095839   .g 2620 to 5001 1 to 2382 exact tiling clone, available from FLJ,   2382/2382
(100 %)
2 diff
(100.0 %id)
DA551545   .g 2621 to 3126 2 to 507   capped   506/506
(100 %)
1 diff
(99.9 %id)
DA096286 cerebellum .g 2712 to 3253 2 to 543   capped   542/542
(100 %)
1 diff
(99.9 %id)
DA318161 hippocampus .g 2765 to 3225 2 to 462   capped   461/461
(100 %)
0 diff
(100 %id)
CN281327 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .g 2826 to 3487 1 to 662       662/662
(100 %)
3 diff
(99.6 %id)
BM718423 eye, fetal eye .g 2868 to 3524 1 to 657       657/657
(100 %)
0 diff
(100 %id)
DB141973 thymus .g 2897 to 3345 2 to 450   capped   449/449
(100 %)
0 diff
(100 %id)
DB151128 thymus .g 2958 to 3535 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
AW999985 breast_normal .g 2986 to 3486 9 to 510       502/511
(98 %)
8 diff
(98.5 %id)
L44570   .g 3149 to 3512 368 to 2       367/373
(98 %)
0 diff
(100 %id)
T62184 lung .g 4309 to 4598 1 to 299   fully sequenced,   299/299
(100 %)
9 diff
(97.0 %id)
BM683476 eye, fetal eye .g 4357 to 5019 663 to 1   tiling clone,   663/663
(100 %)
0 diff
(100 %id)
DB318339   .g 4448 to 5001 554 to 1       554/554
(100 %)
0 diff
(100 %id)
T61955 lung .g 4568 to 5012 451 to 1   fully sequenced,   451/451
(100 %)
12 diff
(97.4 %id)
DB455210.
matches multiple genes
testis .h 1 to 477 1 to 477 A65S tiling clone, also hits gene LOC100129148 477/477
(100 %)
3 diff
(99.4 %id)
BY995399   .i 1 to 663 18 to 680 exact tiling clone,   663/680
(97 %)
6 diff
(99.2 %id)
BM477202 lymph, lymphoma, cell line .j-u 1 to 874 883 to 1 A54S tiling clone, Submitted on the opposite strand 883/1142
(77 %)
24 diff
(97.9 %id)
DB501082.
matches multiple genes
hypothalamus .j-u 319 to 810 1 to 492   tiling clone, also hits gene LOC100129148 492/492
(100 %)
2 diff
(99.6 %id)
AW009633 colon .k 1 to 367 1 to 367   tiling clone, Submitted on the opposite strand 367/367
(100 %)
6 diff
(98.4 %id)
BI117784 lung, small cell carcinoma .k 281 to 959 1 to 681 S8A     681/718
(94 %)
10 diff
(98.7 %id)
ES315160 occipital scalp hair, skin .k 282 to 443 1 to 162       162/162
(100 %)
2 diff
(98.8 %id)
BU624349 cell lines, Enchondroma .k 288 to 965 696 to 19 exact tiling clone, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 678/683
(99 %)
0 diff
(100 %id)
CB125801 Liver .k 301 to 847 1 to 547       547/547
(100 %)
0 diff
(100 %id)
NM_197964.3   .k 301 to 965 1 to 665 exact RefSeq, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 665/665
(100 %)
0 diff
(100 %id)
BM091077 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .k 316 to 873 1 to 558       558/558
(100 %)
4 diff
(99.3 %id)
DA282756 corpus callosum .k 320 to 884 2 to 566 S8A capped   565/565
(100 %)
1 diff
(99.9 %id)
BE857372 brain, glioblastoma (pooled) .k 405 to 965 561 to 1 exact     561/561
(100 %)
0 diff
(100 %id)
FN099654 breast carcinoma .k 451 to 537 90 to 5     Submitted on the opposite strand 86/95
(90 %)
0 diff
(100 %id)
CD700878 normal nasopharynx .k 454 to 953 7 to 506 exact     500/506
(98 %)
8 diff
(98.5 %id)
BQ440830 melanotic melanoma, skin .k 454 to 966 1 to 513 exact     513/940
(54 %)
2 diff
(99.8 %id)
DW466616 Liver .k 472 to 807 16 to 351       336/351
(95 %)
6 diff
(98.3 %id)
DB467872 hippocampus .k 472 to 929 1 to 458 S8A A33G A34G     458/458
(100 %)
4 diff
(99.2 %id)
AF161386 blood .k 476 to 967 1 to 491 T65P Y66I L67S C68A L69S ...     491/495
(99 %)
3 diff
(99.4 %id)
N78510 multiple sclerosis lesions .k 476 to 965 1 to 488 A23X G26X R27H P28X Y29I ... fully sequenced, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 488/488
(100 %)
7 diff
(98.6 %id)
BF664988 brain, primitive neuroectoderm .k 478 to 1121 1 to 633 A3R S8A L18C R19A Y20T ...     633/855
(74 %)
38 diff
(95.6 %id)
BC008467 Brain, primitive neuroectodermal .k 479 to 1491 1 to 1014 S8A tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 1014/1015
(99 %)
6 diff
(99.5 %id)
BX116138 multiple sclerosis lesions .k 479 to 965 1 to 487 exact AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 487/487
(100 %)
0 diff
(100 %id)
CR990414 T-Lymphocytes .k 480 to 965 1 to 486 exact AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 486/486
(100 %)
0 diff
(100 %id)
CB150185 Liver .k 481 to 666 1 to 186       186/186
(100 %)
2 diff
(99.0 %id)
BM793122 Ascites, stomach .k 482 to 866 39 to 423       385/423
(91 %)
20 diff
(95.3 %id)
AI306498 carcinoid, lung .k 491 to 932 1 to 442 exact   Submitted on the opposite strand 442/442
(100 %)
0 diff
(100 %id)
AI306499 carcinoid, lung .k 491 to 941 1 to 451 exact   Submitted on the opposite strand 451/451
(100 %)
0 diff
(100 %id)
AI690271 carcinoid, lung .k 491 to 941 1 to 451 S8A   Submitted on the opposite strand 451/451
(100 %)
6 diff
(98.7 %id)
AI680820 carcinoid, lung .k 491 to 957 1 to 467 G107X   Submitted on the opposite strand 467/467
(100 %)
0 diff
(100 %id)
BE045317 carcinoid, lung .k 491 to 941 1 to 451 S8A   Submitted on the opposite strand 451/451
(100 %)
3 diff
(99.4 %id)
AI914087 carcinoid, lung .k 493 to 734 1 to 242     Submitted on the opposite strand 242/242
(100 %)
1 diff
(99.6 %id)
BF110215 carcinoid, lung .k 493 to 959 1 to 467 S8A   Submitted on the opposite strand 467/467
(100 %)
5 diff
(99.0 %id)
AI681934 carcinoid, lung .k 494 to 960 1 to 467 S8A   Submitted on the opposite strand 467/467
(100 %)
4 diff
(99.2 %id)
AV737414 cord Blood .k 495 to 965 31 to 484 A2R A3P L4* AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 458/484
(94 %)
9 diff
(98.2 %id)
AI292139 carcinoid, lung .k 495 to 952 1 to 458 exact   Submitted on the opposite strand 458/458
(100 %)
0 diff
(100 %id)
BQ889014 melanotic melanoma, cell line, skin .k 497 to 965 1 to 469 exact AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 469/469
(100 %)
0 diff
(100 %id)
BQ680999 melanotic melanoma, cell line, skin .k 497 to 965 1 to 469 exact AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 469/469
(100 %)
0 diff
(100 %id)
BM671225 eye, optic nerve .k 499 to 965 485 to 19 exact AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 467/476
(98 %)
0 diff
(100 %id)
TI_151771558   .k 499 to 965 106 to 572 G5X A24X A34X E50X Q62X ... AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 467/467
(100 %)
5 diff
(99.0 %id)
AA196353 muscle, skeletal muscle .k 501 to 961 1 to 458 G26X R27X P28L Y29S D31H ...     458/458
(100 %)
5 diff
(99.0 %id)
AA196360 muscle, skeletal muscle .k 502 to 958 1 to 454 R27X P28L Y29S D31H T32R ... fully sequenced,   454/454
(100 %)
3 diff
(99.4 %id)
AA196338 muscle, skeletal muscle .k 504 to 952 1 to 448 G26X R27T Y29I R30A D31T ...     448/448
(100 %)
6 diff
(98.7 %id)
AI264128 Kidney .k 511 to 967 458 to 2 exact     457/458
(99 %)
0 diff
(100 %id)
AA469915   .k 512 to 703 1 to 188   fully sequenced,   188/188
(100 %)
3 diff
(98.5 %id)
AA476818   .k 512 to 964 1 to 446 S8A A23R A24P T25P G26A ... fully sequenced,   446/446
(100 %)
7 diff
(98.5 %id)
BM126372 Islets of Langerhans, Pancreas .k 513 to 965 1 to 453 S6T fully sequenced, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 453/453
(100 %)
2 diff
(99.6 %id)
BM091381 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .k 514 to 967 456 to 3 exact     454/456
(99 %)
0 diff
(100 %id)
BU588788 mixed (pool of 40 RNAs) .k 517 to 967 1 to 451 S8A     451/458
(98 %)
6 diff
(98.7 %id)
BG540993 lung .k 519 to 1055 1 to 541 T25P G26A R27D Y29I R30A ...     541/863
(62 %)
25 diff
(97.2 %id)
CB857828 anterior tongue, pooled .k 519 to 964 1 to 446 S90L     446/446
(100 %)
1 diff
(99.8 %id)
BU535276 mixed (pool of 40 RNAs) .k 519 to 962 1 to 444 exact     444/445
(99 %)
2 diff
(99.6 %id)
BU537596 mixed (pool of 40 RNAs) .k 519 to 967 1 to 451 S8A K75E H76T V77C A78G ...     451/492
(91 %)
6 diff
(98.8 %id)
BU532609 mixed (pool of 40 RNAs) .k 520 to 962 1 to 443 exact     443/449
(98 %)
2 diff
(99.6 %id)
AJ708097 heart .k 522 to 937 1 to 416 exact     416/416
(100 %)
6 diff
(98.6 %id)
AI971045 Prostate .k 526 to 965 440 to 1 S8A     440/440
(100 %)
1 diff
(99.8 %id)
TI_154036376   .k 528 to 965 480 to 44 exact AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 437/1013
(43 %)
0 diff
(100 %id)
AJ572593 pectoral muscle (after mastectomy) .k 529 to 967 1 to 439 H9P T10L R12E G13D L14F ...     439/442
(99 %)
6 diff
(98.7 %id)
AI735291 aorta .k 529 to 967 440 to 2 exact     439/440
(99 %)
0 diff
(100 %id)
AI749426 aorta .k 529 to 967 440 to 2 exact     439/440
(99 %)
0 diff
(100 %id)
W84355 heart .k 530 to 738 1 to 206   fully sequenced,   206/206
(100 %)
6 diff
(97.1 %id)
AA025864 heart .k 531 to 966 433 to 1 S6P P7R S8R H9T T10L ...     433/433
(100 %)
12 diff
(97.3 %id)
BQ879182 dorsal root ganglia .k 531 to 965 1 to 435 L21Q AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 435/435
(100 %)
1 diff
(99.8 %id)
BE907087 epithelioid carcinoma, Pancreas .k 532 to 961 1 to 430 S8A     430/430
(100 %)
1 diff
(99.8 %id)
AI269875 Kidney .k 533 to 967 440 to 6 exact     435/440
(98 %)
1 diff
(99.8 %id)
CV027533 mixed .k 535 to 879 1 to 345 S8A R12Q R54K Q105H     345/423
(81 %)
8 diff
(98.2 %id)
BE280253 choriocarcinoma, placenta .k 535 to 965 1 to 431 L4*     431/636
(67 %)
5 diff
(99.3 %id)
DB534996 hippocampus .k 537 to 965 1 to 428   AAA Submitted on the opposite strand 428/428
(100 %)
3 diff
(99.3 %id)
TI_153965439   .k 537 to 966 99 to 528       430/1159
(37 %)
5 diff
(99.6 %id)
BM693181 eye, Retina Foveal and Macular .k 538 to 719 1 to 182   fully sequenced, Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 182/182
(100 %)
0 diff
(100 %id)
AA417880 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .k 544 to 965 416 to 5       412/416
(99 %)
7 diff
(98.4 %id)
BU729921 eye, Retina Foveal and Macular .k 544 to 965 440 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 422/422
(100 %)
1 diff
(99.8 %id)
BE857975 pooled .k 545 to 967 426 to 4       423/426
(99 %)
1 diff
(99.8 %id)
AI870613 anaplastic oligodendroglioma, brain .k 547 to 965 419 to 1       419/419
(100 %)
0 diff
(100 %id)
AI479418 anaplastic oligodendroglioma, brain .k 548 to 966 419 to 1       419/419
(100 %)
0 diff
(100 %id)
AI308072 2 pooled tumors (clear cell type), Kidney .k 551 to 967 419 to 3       417/419
(99 %)
0 diff
(100 %id)
BP397490 pancreatic islet .k 559 to 965 94 to 500     Submitted on the opposite strand 407/500
(81 %)
8 diff
(98.4 %id)
AA780190   .k 563 to 967 406 to 3       404/406
(99 %)
3 diff
(99.3 %id)
BF589340 pooled .k 563 to 967 409 to 5       405/409
(99 %)
0 diff
(100 %id)
AI347395 2 pooled tumors (clear cell type), Kidney .k 567 to 967 408 to 8       401/408
(98 %)
0 diff
(100 %id)
AA935945 carcinoid, lung .k 569 to 980 1 to 410   AAA Submitted on the opposite strand 410/410
(100 %)
7 diff
(98.3 %id)
AI971121 Prostate .k 570 to 967 400 to 3       398/400
(99 %)
0 diff
(100 %id)
AW005093 anaplastic oligodendroglioma, brain .k 571 to 967 398 to 2       397/398
(99 %)
0 diff
(100 %id)
AI273636 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .k 572 to 965 407 to 14   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 394/394
(100 %)
0 diff
(100 %id)
AI469870 pooled .k 572 to 965 406 to 13   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 394/394
(100 %)
0 diff
(100 %id)
BM700818 eye, human retina .k 573 to 965 1 to 393   fully sequenced, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 393/393
(100 %)
0 diff
(100 %id)
AI310114 2 pooled tumors (clear cell type), Kidney .k 601 to 967 370 to 4       367/370
(99 %)
0 diff
(100 %id)
AA026598 heart .k 606 to 965 359 to 1       359/361
(99 %)
4 diff
(98.9 %id)
TI_154191819   .k 610 to 965 50 to 405   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 356/356
(100 %)
0 diff
(100 %id)
CF129923 Chondrosarcoma Lung Metastasis cell lines, lung .k 611 to 965 1 to 355   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 355/355
(100 %)
0 diff
(100 %id)
AW138575   .k 622 to 965 363 to 18   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 346/346
(100 %)
8 diff
(97.7 %id)
AI266465 2 pooled tumors (clear cell type), Kidney .k 625 to 965 356 to 16   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 341/341
(100 %)
1 diff
(99.8 %id)
AI311563 2 pooled tumors (clear cell type), Kidney .k 631 to 967 340 to 4       337/340
(99 %)
0 diff
(100 %id)
AI142657 pooled .k 636 to 967 336 to 5       332/336
(98 %)
0 diff
(100 %id)
AI094689 brain, glioblastoma (pooled) .k 636 to 966 331 to 1       331/331
(100 %)
0 diff
(100 %id)
AI273866 ovary, tumor, 5 pooled (see description) .k 636 to 965 330 to 1       330/330
(100 %)
0 diff
(100 %id)
AA723525 heart .k 638 to 966 328 to 1       328/328
(100 %)
1 diff
(99.7 %id)
AA917590 2 pooled tumors (clear cell type), Kidney .k 638 to 967 331 to 2       330/331
(99 %)
0 diff
(100 %id)
AA975941 carcinoid, lung .k 639 to 965 327 to 1       327/327
(100 %)
0 diff
(100 %id)
AA416858   .k 642 to 967 326 to 2   fully sequenced,   325/326
(99 %)
0 diff
(100 %id)
AA443766   .k 642 to 967 325 to 2   fully sequenced,   324/325
(99 %)
0 diff
(100 %id)
BM126085 Islets of Langerhans, Pancreas .k 642 to 965 338 to 15   fully sequenced, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 324/324
(100 %)
2 diff
(99.4 %id)
BM672187 eye, human retina .k 642 to 965 342 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 324/324
(100 %)
0 diff
(100 %id)
AA626296 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .k 662 to 964 303 to 1       303/303
(100 %)
0 diff
(100 %id)
BM668413 eye, Retina Foveal and Macular .k 689 to 965 295 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 277/277
(100 %)
0 diff
(100 %id)
W84495 heart .k 708 to 879 172 to 1   fully sequenced,   172/172
(100 %)
0 diff
(100 %id)
N73669 multiple sclerosis lesions .k 715 to 965 251 to 1   fully sequenced, Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 251/251
(100 %)
0 diff
(100 %id)
AA192313 muscle, skeletal muscle .k 823 to 972 155 to 2   fully sequenced,   154/155
(99 %)
5 diff
(96.8 %id)
AK094081 uterus .l 1 to 2598 2 to 2599 exact tiling clone, available from FLJ,   2599/2599
(100 %)
0 diff
(100 %id)
DB261272 uterus .l 1 to 562 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DB168014 kidney, tumor tissue .l 64 to 627 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
BE150776 head_neck .l 125 to 601 1 to 478       478/488
(97 %)
6 diff
(98.8 %id)
CV417082 head_neck .l 125 to 601 1 to 478       478/488
(97 %)
6 diff
(98.8 %id)
BE144230 head_neck .l 158 to 758 13 to 611       599/611
(98 %)
6 diff
(99.1 %id)
DA187423 amygdala .l 210 to 748 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA208024 brain .l 399 to 964 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DB256960 uterus .l 586 to 1159 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DA207103 brain .l 739 to 1312 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
BI758379 brain .l 893 to 1723 7 to 840       834/840
(99 %)
11 diff
(98.7 %id)
TI_57218083   .l 893 to 1723 7 to 840       834/840
(99 %)
11 diff
(98.7 %id)
DB351653 uterus .l 2057 to 2598 542 to 1       542/542
(100 %)
0 diff
(100 %id)
DB304272 brain .l 2065 to 2598 535 to 1       535/535
(100 %)
2 diff
(99.7 %id)
BX119501 uterus .m 1 to 751 1 to 751   tiling clone,   751/751
(100 %)
1 diff
(99.9 %id)
BE045661 carcinoid, lung .m 321 to 845 527 to 3   tiling clone,   525/527
(99 %)
0 diff
(100 %id)
BQ924452 brain, neuroblastoma, cell line .m 814 to 1673 1 to 861 A6V R27* tiling clone,   861/879
(97 %)
7 diff
(99.3 %id)
BF438613 pooled .m 1373 to 1670 298 to 1   tiling clone,   298/330
(90 %)
0 diff
(100 %id)
BQ026241 placenta .m 1405 to 1670 284 to 19   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 266/266
(100 %)
0 diff
(100 %id)
CV573589 cornea, eye .n 1 to 617 1 to 617 exact tiling clone,   617/618
(99 %)
1 diff
(99.9 %id)
DB167505 kidney, tumor tissue .o 1 to 565 2 to 567   tiling clone, capped   566/566
(100 %)
2 diff
(99.7 %id)
BM413641 eye, retinoblastoma .o 6 to 524 10 to 529       520/1222
(42 %)
14 diff
(98.9 %id)
DB208196 trachea .o 34 to 576 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DA124079 cerebellum .o 50 to 519 2 to 473   capped   472/472
(100 %)
3 diff
(99.4 %id)
DA306965 hippocampus .o 50 to 626 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DB454723.
matches multiple genes
testis .o 57 to 528 1 to 472     also hits gene LOC100129148 472/472
(100 %)
1 diff
(99.8 %id)
DA960249 Spleen .o 74 to 629 2 to 557 exact tiling clone, capped   556/556
(100 %)
0 diff
(100 %id)
DA100769 cerebellum .p-u 1 to 571 2 to 575   tiling clone, to resequence, capped   574/575
(99 %)
7 diff
(98.8 %id)
DB292354 uterus .p-u 1234 to 1828 2 to 597   tiling clone, capped   596/597
(99 %)
23 diff
(96.2 %id)
CN363312 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .p-u 1243 to 1941 1 to 703   tiling clone,   703/703
(100 %)
7 diff
(99.1 %id)
BC041001 Brain, hippocampus .p-u 1256 to 5917 1 to 4674 S41* tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 4674/4675
(99 %)
27 diff
(99.5 %id)
Z30289   .p-u 1257 to 1583 1 to 327       327/327
(100 %)
0 diff
(100 %id)
AA912320 Dorsal root ganglion, peripheral nervous system .p-u 1324 to 1601 278 to 1       278/278
(100 %)
3 diff
(99.0 %id)
AW593663 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .p-u 1397 to 1591 206 to 12       195/206
(94 %)
0 diff
(100 %id)
AA114983 uterus .p-u 1438 to 1773 1 to 340   fully sequenced,   340/340
(100 %)
6 diff
(98.3 %id)
BX101203 uterus .p-u 1440 to 2139 1 to 703       703/703
(100 %)
3 diff
(99.6 %id)
CN363310 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .p-u 1478 to 1935 1 to 458   tiling clone,   458/458
(100 %)
0 diff
(100 %id)
N98890 lung .p-u 1604 to 2046 1 to 458   fully sequenced,   458/458
(100 %)
17 diff
(96.3 %id)
DA687959   .p-u 1605 to 1922 2 to 320   capped   319/547
(58 %)
2 diff
(99.7 %id)
AA318987 adrenal gland .p-u 1614 to 1861 248 to 1     Submitted on the opposite strand 248/248
(100 %)
0 diff
(100 %id)
CN363309 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .p-u 1616 to 2218 1 to 603       603/603
(100 %)
0 diff
(100 %id)
BM992602 lung, Metastatic Chondrosarcoma .p-u 1640 to 2300 679 to 19   AAA   661/661
(100 %)
2 diff
(99.7 %id)
AA249704   .p-u 1652 to 1933 1 to 282       282/282
(100 %)
8 diff
(97.2 %id)
AA043552 uterus .p-u 1689 to 2300 604 to 1       604/695
(86 %)
13 diff
(98.2 %id)
AI935496 Kidney .p-u 1697 to 2031 371 to 37   AAA   335/352
(95 %)
0 diff
(100 %id)
AA643521 colon, colon tumor RER+ .p-u 1724 to 2273 550 to 1       550/550
(100 %)
2 diff
(99.7 %id)
CB049134 Prostate .p-u 1725 to 2156 1 to 432       432/432
(100 %)
8 diff
(98.2 %id)
BE930218 placenta_normal .p-u 1742 to 2091 346 to 1       346/346
(100 %)
5 diff
(98.6 %id)
BE930378 placenta_normal .p-u 1742 to 2111 402 to 35       368/402
(91 %)
0 diff
(100 %id)
AA115116 uterus .p-u 1743 to 2300 559 to 1   fully sequenced,   559/559
(100 %)
5 diff
(99.2 %id)
BE930216 placenta_normal .p-u 1760 to 2105 30 to 375       346/375
(92 %)
8 diff
(97.9 %id)
AI971617 pooled germ cell tumors .p-u 1766 to 2287 540 to 19       522/540
(96 %)
0 diff
(100 %id)
AI742152 pooled .p-u 1767 to 2301 540 to 6       535/540
(99 %)
0 diff
(100 %id)
AW581276 leiomios .p-u 1773 to 2167 1 to 394       394/394
(100 %)
6 diff
(98.5 %id)
AI703414 carcinoid, lung .p-u 1774 to 2299 526 to 1       526/526
(100 %)
4 diff
(99.3 %id)
BF195310 carcinoid, lung .p-u 1779 to 2301 526 to 5       522/526
(99 %)
0 diff
(100 %id)
BQ029141 lung, Metastatic Chondrosarcoma .p-u 1779 to 2300 540 to 19   AAA   522/522
(100 %)
2 diff
(99.7 %id)
AW003679 Prostate .p-u 1787 to 2301 517 to 3       515/517
(99 %)
0 diff
(100 %id)
BF000458 colon, colon tumor, RER+ .p-u 1790 to 2296 524 to 18   AAA   507/514
(98 %)
0 diff
(100 %id)
AI653546 ovary, tumor, 5 pooled (see description) .p-u 1792 to 2301 516 to 7       510/516
(98 %)
0 diff
(100 %id)
CV386936 placenta_normal .p-u 1801 to 2105 9 to 317       309/317
(97 %)
6 diff
(98.2 %id)
AA514699 colon .p-u 1821 to 2303 483 to 1       483/483
(100 %)
0 diff
(100 %id)
BF084941 prostate_tumor .p-u 1829 to 2048 8 to 227       220/229
(96 %)
3 diff
(98.7 %id)
AW972002   .p-u 1831 to 2302 479 to 1     Submitted on the opposite strand 479/506
(94 %)
11 diff
(97.9 %id)
BF476373 Prostate .p-u 1833 to 2300 468 to 1       468/468
(100 %)
2 diff
(99.6 %id)
AI193828 lung .p-u 1838 to 2301 469 to 6       464/469
(98 %)
0 diff
(100 %id)
AI024281   .p-u 1844 to 2304 463 to 3   tiling clone,   461/463
(99 %)
0 diff
(100 %id)
AA505420 breast .p-u 1846 to 2301 456 to 1       456/456
(100 %)
0 diff
(100 %id)
BG680714 skin, squamous cell carcinoma .p-u 1846 to 2649 1 to 796       796/797
(99 %)
9 diff
(98.9 %id)
AA976664 carcinoid, lung .p-u 1849 to 2301 453 to 1       453/453
(100 %)
4 diff
(99.2 %id)
AI659263 Prostate .p-u 1849 to 2300 452 to 1       452/452
(100 %)
3 diff
(99.4 %id)
AA999980 Kidney .p-u 1850 to 2301 453 to 3       451/453
(99 %)
0 diff
(100 %id)
BQ021887 placenta .p-u 1853 to 2300 465 to 18   AAA   448/448
(100 %)
2 diff
(99.6 %id)
AA156252 uterus .p-u 1866 to 2296 436 to 5       432/445
(97 %)
0 diff
(100 %id)
BF589471 Prostate .p-u 1881 to 2301 421 to 1       421/421
(100 %)
1 diff
(99.8 %id)
BE856053 Prostate .p-u 1881 to 2300 431 to 12   AAA   420/420
(100 %)
1 diff
(99.8 %id)
BM069835 Islets of Langerhans, Pancreas .p-u 1885 to 2303 1 to 419   AAA   419/419
(100 %)
1 diff
(99.8 %id)
BM127060 Islets of Langerhans, Pancreas .p-u 1887 to 2300 1 to 414       414/414
(100 %)
0 diff
(100 %id)
BM126398 Islets of Langerhans, Pancreas .p-u 1887 to 2300 1 to 414       414/414
(100 %)
0 diff
(100 %id)
AA781667   .p-u 1898 to 2300 403 to 1       403/403
(100 %)
0 diff
(100 %id)
BF063433 colon, colon tumor, RER+ .p-u 1902 to 2300 399 to 1       399/399
(100 %)
1 diff
(99.8 %id)
FN051694 breast carcinoma .p-u 1921 to 2020 101 to 1     Submitted on the opposite strand 101/102
(99 %)
1 diff
(99.1 %id)
BE714189 head_neck .p-u 1940 to 2149 218 to 8       211/226
(93 %)
0 diff
(100 %id)
BG150050 carcinoid, lung .p-u 1954 to 2301 350 to 3       348/350
(99 %)
0 diff
(100 %id)
AI051101 parathyroid gland, parathyroid tumor .p-u 1981 to 2301 326 to 6       321/326
(98 %)
0 diff
(100 %id)
AI432115 adenocarcinoma, Pancreas .p-u 1996 to 2301 313 to 8       306/313
(97 %)
0 diff
(100 %id)
BU753742 placenta .p-u 1996 to 2300 322 to 18   AAA   305/305
(100 %)
1 diff
(99.7 %id)
AA232752 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .p-u 1997 to 2288 1 to 292   fully sequenced,   292/292
(100 %)
0 diff
(100 %id)
AA935707 carcinoid, lung .p-u 2007 to 2299 293 to 1       293/293
(100 %)
2 diff
(99.4 %id)
N69899 lung .p-u 2016 to 2303 308 to 17   fully sequenced, AAA   292/292
(100 %)
4 diff
(98.7 %id)
AA610774 thyroid .p-u 2024 to 2301 305 to 28       278/305
(91 %)
0 diff
(100 %id)
BF110349 carcinoid, lung .p-u 2054 to 2301 250 to 3       248/250
(99 %)
0 diff
(100 %id)
BG001845 placenta_normal .p-u 2119 to 2479 359 to 1       359/431
(83 %)
3 diff
(99.4 %id)
BE930021 placenta_normal .p-u 2146 to 2483 337 to 1       337/337
(100 %)
4 diff
(98.9 %id)
DB237007 trachea .p-u 2169 to 2717 2 to 551   tiling clone, capped   550/550
(100 %)
1 diff
(99.9 %id)
AW370213 breast .p-u 2193 to 2431 1 to 238       238/238
(100 %)
9 diff
(96.3 %id)
DB163984 thymus .p-u 2210 to 2807 2 to 601   capped   600/600
(100 %)
2 diff
(99.7 %id)
AA232255 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .p-u 2228 to 2300 73 to 1   fully sequenced,   73/73
(100 %)
0 diff
(100 %id)
DA097582 cerebellum .p-u 2229 to 2799 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
BX952403   .p-u 2690 to 3226 1 to 537   tiling clone,   537/537
(100 %)
0 diff
(100 %id)
BU188538 melanotic melanoma, skin .p-u 2770 to 3227 1 to 458       458/855
(53 %)
3 diff
(99.7 %id)
DA300117 hippocampus .p-u 3439 to 4017 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DA229783 brain .p-u 3447 to 4055 2 to 610   capped   609/616
(98 %)
4 diff
(99.4 %id)
AI951471 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .p-u 3529 to 3833 307 to 3       305/439
(69 %)
0 diff
(100 %id)
DN912908   .p-u 3531 to 4005 178 to 651       474/651
(72 %)
6 diff
(99.1 %id)
BF103602 embryonal carcinoma, testis .p-u 3621 to 4200 1 to 572       572/822
(69 %)
16 diff
(98.1 %id)
DN912907   .p-u 3673 to 4380 707 to 6   tiling clone,   702/710
(98 %)
0 diff
(100 %id)
DB242346 stomach, tumor tissue .p-u 3831 to 4403 2 to 574   capped   573/573
(100 %)
4 diff
(99.4 %id)
BE771104 prostate_tumor .p-u 4001 to 4280 284 to 3       282/291
(96 %)
0 diff
(100 %id)
BE771109 prostate_tumor .p-u 4001 to 4360 362 to 4       359/369
(97 %)
0 diff
(100 %id)
BE829633 lung_tumor .p-u 4001 to 4360 390 to 31       360/399
(90 %)
0 diff
(100 %id)
BE836857 prostate_normal .p-u 4001 to 4283 283 to 1       283/290
(97 %)
4 diff
(98.7 %id)
AI911240 pooled .p-u 4062 to 4343 311 to 30   AAA   282/292
(96 %)
0 diff
(100 %id)
BE836861 prostate_normal .p-u 4085 to 4360 1 to 277       277/293
(94 %)
12 diff
(96.0 %id)
Z36251   .p-u 4102 to 4488 1 to 386       386/386
(100 %)
2 diff
(99.5 %id)
BE771107 prostate_tumor .p-u 4109 to 4347 241 to 2       240/329
(72 %)
0 diff
(100 %id)
BX102491 whole brain .p-u 4137 to 4674 1 to 538   tiling clone,   538/538
(100 %)
0 diff
(100 %id)
H06466 whole brain .p-u 4138 to 4678 1 to 544     Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 544/544
(100 %)
7 diff
(98.8 %id)
BF028496 bladder, carcinoma, cell line .p-u 4198 to 4808 1 to 615       615/728
(84 %)
19 diff
(97.4 %id)
CF134880 CNCAP(3)T-225 cell line, Prostate .p-u 4310 to 4606 8 to 304       297/304
(97 %)
6 diff
(98.1 %id)
TI_154162988   .p-u 4310 to 4810 81 to 589 K42X R69P K70E R82K S83I ...     509/840
(60 %)
17 diff
(98.0 %id)
CR590537 fetal brain .p-u 4355 to 5615 1 to 1261 exact tiling clone,   1261/1261
(100 %)
0 diff
(100 %id)
AL538412 brain, fetal brain .p-u 4355 to 5336 1 to 982 A94Z E96R I97S fully sequenced,   982/982
(100 %)
11 diff
(98.9 %id)
DB307990 hippocampus .p-u 5054 to 5585 532 to 1       532/532
(100 %)
0 diff
(100 %id)
DB298830 cerebellum .p-u 5070 to 5626 563 to 7       557/563
(98 %)
0 diff
(100 %id)
DB353093 uterus .p-u 5076 to 5623 548 to 1       548/549
(99 %)
0 diff
(100 %id)
H06195 whole brain .p-u 5193 to 5632 452 to 16   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 437/448
(97 %)
14 diff
(96.9 %id)
AL567294 brain, fetal brain .p-u 5306 to 5615 310 to 1   fully sequenced,   310/310
(100 %)
5 diff
(98.4 %id)
DB299102 cerebellum .p-u 5360 to 5922 563 to 1   to resequence,   563/566
(99 %)
6 diff
(99.0 %id)
DA239432 brain .q-u 1 to 592 2 to 596   tiling clone, capped   595/595
(100 %)
3 diff
(99.5 %id)
DA231420 brain .q-u 24 to 557 2 to 536   capped   535/535
(100 %)
1 diff
(99.9 %id)
AI299404 carcinoid, lung .q-u 86 to 532 449 to 4   tiling clone,   446/449
(99 %)
0 diff
(100 %id)
DA073520 cerebellum .q-u 860 to 1432 2 to 574   tiling clone, capped   573/573
(100 %)
0 diff
(100 %id)
DA367173 subthalamic nucleus .q-u 860 to 1423 2 to 567   capped   566/566
(100 %)
6 diff
(99.0 %id)
DB126579 thymus .q-u 862 to 1407 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
CN366596 embryonic stem cells, DMSO-treated H9 cellline .q-u 877 to 1513 9 to 645 D73N     637/645
(98 %)
6 diff
(99.1 %id)
AK093018 Spleen .q-u 891 to 3454 1 to 2564 exact tiling clone, available from FLJ,   2564/2564
(100 %)
1 diff
(100.0 %id)
DA944720 Spleen .q-u 892 to 1455 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DB333436 Spleen .q-u 2911 to 3454 544 to 1       544/544
(100 %)
0 diff
(100 %id)
DB305856 brain .q-u 2917 to 3454 538 to 1       538/538
(100 %)
7 diff
(98.7 %id)
AI951379 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .q-u 2989 to 3459 471 to 1   tiling clone,   471/471
(100 %)
0 diff
(100 %id)
DB086483 testis .r 1 to 558 2 to 559   tiling clone, capped   558/558
(100 %)
0 diff
(100 %id)
DB236576 trachea .r 5 to 461 2 to 459   capped   458/470
(97 %)
2 diff
(99.6 %id)
TI_44350956   .r 9 to 344 129 to 464       336/665
(50 %)
6 diff
(99.1 %id)
TI_44349501   .r 13 to 334 84 to 404   AAA   321/627
(51 %)
4 diff
(99.4 %id)
DA935648 Spleen .r 39 to 630 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
DA447604 tongue, tumor tissue .r 47 to 615 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA416587 thalamus .r 417 to 983 2 to 568   tiling clone, capped   567/567
(100 %)
0 diff
(100 %id)
BE144616 head_neck .r 675 to 892 219 to 1     Submitted on the opposite strand 219/219
(100 %)
1 diff
(99.6 %id)
DA386412 thalamus .s 1 to 570 2 to 571   tiling clone, capped   570/570
(100 %)
0 diff
(100 %id)
BM456388 lymph, lymphoma, cell line .s 32 to 887 1 to 861 S20X D21* tiling clone,   861/867
(99 %)
10 diff
(98.9 %id)
DB175846 kidney, tumor tissue .s 35 to 593 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BM799595 eye, retinoblastoma .t 1 to 702 1 to 704 E15G R16E M17N S19F M20N ... tiling clone,   704/1152
(61 %)
11 diff
(99.1 %id)
AA398842   .u 1 to 280 1 to 280   tiling clone, fully sequenced,   280/280
(100 %)
1 diff
(99.7 %id)
AA435851   .u 250 to 594 345 to 2 C14S V15* tiling clone, fully sequenced,   344/345
(99 %)
0 diff
(100 %id)
AA248888   .u 401 to 591 185 to 1     Submitted on the opposite strand 185/208
(88 %)
14 diff
(93.3 %id)
DB017032 esophageal, tumor tissue .va 1 to 577 2 to 579 exact tiling clone, capped   578/578
(100 %)
2 diff
(99.7 %id)
DB084799 testis .vb 1 to 571 2 to 572   tiling clone, capped   571/571
(100 %)
0 diff
(100 %id)
DA714337   .vc 1 to 550 2 to 551 exact tiling clone, capped   550/550
(100 %)
2 diff
(99.7 %id)
BU659664 blood .vd-u 1 to 471 1 to 467 exact tiling clone,   467/467
(100 %)
17 diff
(96.4 %id)
BU852633 testis .ve 1 to 465 1 to 465 exact     465/471
(98 %)
3 diff
(99.4 %id)
BU568705 testis .ve 2 to 464 1 to 463 I10T tiling clone,   463/466
(99 %)
4 diff
(99.2 %id)
BU568922 testis .ve 43 to 464 1 to 422 exact     422/427
(98 %)
4 diff
(99.1 %id)
AI016087   .ve 58 to 467 421 to 13 exact AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 409/409
(100 %)
1 diff
(99.8 %id)
BU963482 mixed (pool of 40 RNAs) .ve 60 to 464 1 to 405 exact     405/803
(50 %)
3 diff
(99.7 %id)
D81712 brain .ve 61 to 462 1 to 401 A16D S17P G18E N19T M20C ...     401/401
(100 %)
2 diff
(99.6 %id)
BF445341 carcinoid, lung .ve 71 to 469 400 to 2 exact     399/400
(99 %)
0 diff
(100 %id)
BM664195 eye, RPE and Choroid .ve 84 to 467 402 to 19 exact AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 384/400
(96 %)
0 diff
(100 %id)
AI300972 carcinoid, lung .ve 89 to 466 378 to 1 exact     378/378
(100 %)
0 diff
(100 %id)
AI366709 anaplastic oligodendroglioma, brain .ve 94 to 469 383 to 8 exact     376/383
(98 %)
0 diff
(100 %id)
AI138856   .ve 100 to 467 378 to 11 exact AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 368/368
(100 %)
0 diff
(100 %id)
AI138857   .ve 100 to 467 378 to 11 exact AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 368/368
(100 %)
0 diff
(100 %id)
AI187411   .ve 100 to 467 380 to 13 exact AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 368/368
(100 %)
0 diff
(100 %id)
AA770226   .ve 113 to 466 353 to 1 C14A V15*     353/353
(100 %)
1 diff
(99.8 %id)
BF446095 Prostate .ve 113 to 467 355 to 1 exact     355/355
(100 %)
0 diff
(100 %id)
AI681313 carcinoid, lung .ve 119 to 446 1 to 329 exact   Submitted on the opposite strand 329/329
(100 %)
2 diff
(99.4 %id)
AW612658 carcinoid, lung .ve 119 to 446 1 to 328 exact   Submitted on the opposite strand 328/328
(100 %)
0 diff
(100 %id)
AI208569   .ve 125 to 469 356 to 12 exact     345/356
(96 %)
0 diff
(100 %id)
BI825313 brain, medulla .ve 132 to 467 1 to 336 exact AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 336/336
(100 %)
0 diff
(100 %id)
TI_57170537   .ve 132 to 467 36 to 371 exact tiling clone, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 336/371
(90 %)
6 diff
(98.4 %id)
AI078265   .ve 166 to 469 305 to 2 exact     304/424
(71 %)
0 diff
(100 %id)
BG218215   .ve 167 to 467 44 to 342 A12V AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 299/342
(87 %)
8 diff
(97.7 %id)
BG212243   .ve 171 to 467 1 to 297 A16G AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 297/297
(100 %)
4 diff
(98.7 %id)
BG209781   .ve 173 to 467 1 to 295 exact AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 295/295
(100 %)
4 diff
(98.7 %id)
BF511047   .ve 185 to 467 300 to 18 exact AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 283/283
(100 %)
1 diff
(99.7 %id)
AI919372 anaplastic oligodendroglioma, brain .ve 186 to 469 286 to 3 exact     284/287
(98 %)
0 diff
(100 %id)
BM924406 pooled colon, kidney, stomach .ve 190 to 467 1 to 278 exact AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 278/278
(100 %)
0 diff
(100 %id)
BU960652 mixed (pool of 40 RNAs) .ve 204 to 467 1 to 264 exact AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 264/264
(100 %)
3 diff
(98.9 %id)
AI735033 colon .ve 215 to 463 253 to 5       249/253
(98 %)
0 diff
(100 %id)
AI804297 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .ve 250 to 469 225 to 6       220/225
(97 %)
0 diff
(100 %id)
AA620996   .vf 1 to 432 433 to 2 exact tiling clone,   432/433
(99 %)
0 diff
(100 %id)
AA806060 germinal center B cell .vg-u 1 to 406 436 to 32 C14S V15* tiling clone, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 405/405
(100 %)
1 diff
(99.8 %id)
AA393224   .vh 1 to 386 1 to 383 A16H S17P G18E N19T M20C ... tiling clone, fully sequenced,   383/383
(100 %)
7 diff
(98.2 %id)
AA416923   .vh 62 to 404 345 to 2 exact tiling clone, fully sequenced,   344/345
(99 %)
0 diff
(100 %id)
BG981604 colon_normal .vi-u 1 to 167 1 to 168 D2A E32D tiling clone,   168/168
(100 %)
11 diff
(93.5 %id)
BE929507 placenta_normal .vj-u 1 to 143 152 to 10 exact tiling clone,   143/158
(90 %)
0 diff
(100 %id)
AV703782 adrenal gland Gene C7orf55andLUC7L2, variant not shown         Suspected internal deletion, this clone was ignored    
AK093864 trachea Gene C7orf55andLUC7L2, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
BF816418 colon_ins Gene C7orf55andLUC7L2, variant not shown         Suspected internal deletion, this clone was ignored    
DA267183 caudate nucleus Gene C7orf55andLUC7L2, variant not shown       capped Suspected internal deletion, this clone was ignored    
AI433833 Kidney Gene C7orf55andLUC7L2, variant not shown         This clone was ignored    
AI867371 colon, colon tumor, RER+ Gene C7orf55andLUC7L2, variant not shown         Suspected internal deletion, this clone was ignored    
BG818090 anaplastic oligodendroglioma with 1p/19qloss, brain Gene C7orf55andLUC7L2, variant not shown              
BM008129 Spleen Gene C7orf55andLUC7L2, variant not shown         Suspected internal deletion, this clone was ignored    
TI_59383609   Gene C7orf55andLUC7L2, variant not shown         Suspected internal deletion, this clone was ignored    
DB371625 ovary, tumor tissue Gene C7orf55andLUC7L2, variant not shown         This clone was ignored    
DA812277 ovary, tumor tissue Gene C7orf55andLUC7L2, variant not shown       capped This clone was ignored    
DB225817 trachea Gene C7orf55andLUC7L2, variant not shown       capped Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k, .l, .m, .n, .o, .p-u, .q-u, .r, .s, .t, .u, .va, .vb, .vc, .vd-u, .ve, .vf, .vg-u, .vh, .vi-u, .vj-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI